Neuphoria Therapeutics Inc. ( NEUP) - Key Metrics
NEUP Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q4 | $0.22 | -$0.91 | -$2,280.31 | -$2,280.31 |
| 2026Q3 | $0 | -$0.09 | -$0.72 | -$0.72 |
| 2026Q2 | $0 | $0.41 | -$1.42 | -$1.42 |
| 2026Q1 | $0 | -$6.67 | -$1.69 | -$1.69 |
| 2025Q4 | -$6.45 | -$9.15 | $45.33 | $45.33 |
NEUP Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q4 | 0% | -1.20 |
| 2026Q3 | 0% | -10.91 |
| 2026Q2 | 0% | 2.37 |
| 2026Q1 | 0% | -0.44 |
| 2025Q4 | 0% | -0.38 |
NEUP
Price: $3.46
52 week price:
Earnings Per Share: -3.06 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 18.2 million